InSilico Medicine Cayman TopCo company profile
Company profile
InSilico Medicine Cayman TopCo has 333 employees and is headquartered in Hong Kong, Hong Kong.
Employing 333 people, InSilico Medicine Cayman TopCo applies artificial intelligence to drug discovery and development through its proprietary Pharma.AI platform, which offers target identification, small molecule generation and clinical outcome prediction. Its pipeline covers fibrosis, oncology, immunology, metabolic and anti-pain programs, and its work runs through research and development collaborations with partners including Takeda and Servier, as well as a strategic agreement with Suzhou Ribo Life Science on oligonucleotide therapeutics. The group operates in Hong Kong, the United States, the United Kingdom, Japan, Germany, Mainland China and other markets.
In the fiscal year ended December 2025, revenue was USD 56.2 million, down 34.5% from the previous year, and the company reported a net loss of USD 352.3 million. Founded in 2014, InSilico Medicine is based in the New Territories of Hong Kong.
Company facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Hong Kong SAR China
- Headquarters
- Building 8W, Phase 2, Hong Kong
- Employees
- 333
- Founded
- 2014
- Fiscal year
- January - December
- Listing
- 3696 · HKEX
- Currency
- HKD
- ISIN
- KYG4790P1037
- Website
- insilico.com
InSilico Medicine Cayman TopCo and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| InSilico Medicine Cayman TopCo3696 | Hong Kong SAR China | $2.59B | 333 | -6.9% | — |
| Telix PharmaceuticalsTLX | Australia | $2.92B | 1,120 | 6.2% | 92.3 |
| Neuren PharmaceuticalsNEU | Australia | $1.83B | 8 | 19.9% | 144.0 |
| MesoblastMSB | Australia | $1.48B | 108 | -42.6% | — |
| 3SBio1530 | Hong Kong SAR China | $4.56B | 6,068 | 60.3% | 3.90 |
| Metis TechBio7666 | Hong Kong SAR China | $1.11B | 150 | -131.2% | — |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
